New drug aims to tame rare, Multi-Organ autoimmune disease

NCT ID NCT04540497

Ongoing Disease control Sponsor: Amgen Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a drug called inebilizumab can prevent disease flares in people with IgG4-Related Disease (IgG4-RD), a condition where the immune system attacks the body's own tissues in multiple organs. About 135 adults with active IgG4-RD who are at high risk of flare-ups will receive either the study drug or a placebo (inactive substance) by IV infusion over 52 weeks, along with a standard steroid taper. The main goal is to see if the drug helps people stay flare-free for longer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Viela Bio Investigative Siite

Tlalpan, Mexico
Viela Bio Investigative Site

Guandong, China
Viela Bio Investigative Site

Shang’ai, China
Viela Bio Investigative Site

Shenyang, China
Viela Bio Investigative Site

Wuhan, China
Viela Bio Investigative Site

Clichy, France
Viela Bio Investigative Site

Lille, France
Viela Bio Investigative Site

Marseille, France
Viela Bio Investigative Site

Nantes, France
Viela Bio Investigative Site

Pessac, France
Viela Bio Investigative Site

Berlin, Germany
Viela Bio Investigative Site

Lübeck, Germany
Viela Bio Investigative Site

München, Germany
Viela Bio Investigative Site

Palo Alto, California, 94305, United States
Viela Bio Investigative Site

Atlanta, Georgia, 30322, United States
Viela Bio Investigative Site

Baltimore, Maryland, 21287, United States
Viela Bio Investigative Site

Boston, Massachusetts, 02114, United States
Viela Bio Investigative Site

Buenos Aires, Argentina
Viela Bio Investigative Site

Mendoza, Argentina
Viela Bio Investigative Site

Auchenflower, Queensland, Australia
Viela Bio Investigative Site

Adelaide, South Australia, Australia
Viela Bio Investigative Site

Fitzroy, Australia
Viela Bio Investigative Site

Sherbrooke, Canada
Viela Bio Investigative Site

Hohhot, Inner Mongolia, China
Viela Bio Investigative Site

Hong Kong, Hong Kong
Viela Bio Investigative Site

Debrecen, Hungary
Viela Bio Investigative Site

Szeged, Hungary
Viela Bio Investigative Site

Bangalore, India
Viela Bio Investigative Site

Cork, Ireland
Viela Bio Investigative Site

Kfar Saba, Israel
Viela Bio Investigative Site

Petah Tikva, Israel
Viela Bio Investigative Site

Tel Aviv, Israel
Viela Bio Investigative Site

Tel Litwinsky, Israel
Viela Bio Investigative Site

Florence, Italy
Viela Bio Investigative Site

Milan, Italy
Viela Bio Investigative Site

Pisa, Italy
Viela Bio Investigative Site

Reggio Emilia, Italy
Viela Bio Investigative Site

Torino, Italy
Viela Bio Investigative Site

Verona, Italy
Viela Bio Investigative Site

Fukuoka, Japan
Viela Bio Investigative Site

Hokkaido, Japan
Viela Bio Investigative Site

Hyōgo, Japan
Viela Bio Investigative Site

Ishikawa, Japan
Viela Bio Investigative Site

Kyoto, Japan
Viela Bio Investigative Site

Niigata, Japan
Viela Bio Investigative Site

Osaka, Japan
Viela Bio Investigative Site

Tokyo, Japan
Viela Bio Investigative Site

Toyama, Japan
Viela Bio Investigative Site

Amsterdam, Netherlands
Viela Bio Investigative Site

Rotterdam, Netherlands
Viela Bio Investigative Site

Warsaw, Poland
Viela Bio Investigative Site

Wroclaw, Poland
Viela Bio Investigative Site

Barcelona, Spain
Viela Bio Investigative Site

Madrid, Spain
Viela Bio Investigative Site

Valencia, Spain
Viela Bio Investigative Site

Gothenburg, Sweden
Viela Bio Investigative Site

Stockholm, Sweden
Viela Bio Investigative Site

Ankara, Turkey (Türkiye)
Viela Bio Investigative Site

Istanbul, Turkey (Türkiye)
Viela Bio Investigative Site

Leeds, United Kingdom
Viela Bio Investigative Site

London, United Kingdom
Viela Bio Investigative Site

Newcastle, United Kingdom
Viela Bio Investigative Site

Oxford, United Kingdom
Viela Bio Investigative Site 1

Toronto, Canada
Viela Bio Investigative Site 1

Beijing, China
Viela Bio Investigative Site 2

Toronto, Canada
Viela Bio Investigative Site 2

Beijing, China
Viela Bio Investigative Site 2

Osaka, Japan
Viela Bio Investigative Site 2

Barcelona, Spain
Viela Bio Investigative Site 3

Beijing, China
Viela Bio Investigative Site 4

Beijing, China
Viela Bio Investigative Site 5

Beijing, China

Conditions

Explore the condition pages connected to this study.

IGG4 RELATED DISEASE